Sign In
Get Clay Free →

Suggestions

    David Mace

    EIR at 8VC

    David Mace is the Co-founder and Chief Executive Officer of SwiftScale Biologics, a life sciences startup based in San Francisco, California. The company focuses on accelerating the time to market for protein drugs by transforming the labor-intensive drug production scale-up process into a computational challenge.12 Before founding SwiftScale Biologics, David was an Entrepreneur in Residence at 8VC, where he concentrated on the intersection of biology and computer science.13 He holds a degree from the California Institute of Technology.2

    SwiftScale Biologics is known for its innovative approach to biologics manufacturing through cell-free protein synthesis, which allows for faster and more consistent production processes.3 The company was acquired by National Resilience, Inc. in December 2021, after which David Mace and his team joined Resilience to continue developing this technology.4

    Highlights

    Dec 2 · biospace.com
    Resilience Acquires SwiftScale Biologics, a Leader in Cell-Free ...
    Mar 30 · news-medical.net
    SwiftScale Biologics: Cell-Free Synthesis of Biologics - News-Medical
    SwiftScale Biologics: Cell-Free Synthesis of Biologics - News-Medical
    May 26 · soundcloud.com
    15. David Mace, Co-Founder and CEO, SwiftScale Biologics
    15. David Mace, Co-Founder and CEO, SwiftScale Biologics
    May 26 · biotech2050.com
    Ep. 15 - David Mace, Chief Executive Officer, SwiftScale Bio

    Related Questions

    What is cell-free protein synthesis?
    How does SwiftScale Biologics' technology accelerate drug production?
    What was David Mace's role at 8VC?
    How does SwiftScale Biologics' partnership with Sartorius benefit both parties?
    What are the main challenges in scaling up protein drug production?
    David Mace
    David Mace, photo 1
    David Mace, photo 2
    Get intro to David
    Add to my network

    Location

    San Jose, California